Comment on Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213

Medicina (Kaunas). 2022 Jun 6;58(6):766. doi: 10.3390/medicina58060766.

Ahmed Aljabali^{1

2}, Maha Abdo^{1

3}, Ahmed Negida^{1

4

5}

¹ Neuroscience Department, Medical Research Group of Egypt, Zagazig 44523, Egypt.
² Faculty of Medicine, Jordan University of Science & Technology, Irbid 22110, Jordan.
³ Arab Council for Health Specializations, Sana'a 11274, Yemen.
⁴ Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt.
⁵ School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth PO1 2DT, UK.

Abstract

We read with interest the article by Abbas et al. [...].

This research received no external funding.